Publications by authors named "Lars Stovner"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

507,482

Total Likes

8,251

Extended Reach

1,850,328

Social Features

77
G
GBD, secondary analyses, paper mills and abuse of a valuable but vulnerable resource: A problem that must be confronted.
Andreas Kattem Husøy, Lars Jacob Stovner, Timothy J Steiner

Cephalalgia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial.
Lise Rystad Øie, Tore Wergeland, Øyvind Salvesen, G Ril Bruvik Gravdahl, Irina Aschehoug, Lars Jacob Stovner

Lancet Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The global prevalence of headache disorders of public-health importance: a meta-analysis of population-based individual participant data from 41,614 adults from 17 countries.
Andreas Kattem Husøy, Shengyuan Yu, Ruozhuo Liu, Akbar A Herekar, Bilal Ahmed, Lars Jacob Stovner

J Headache Pain· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Global Campaign against Headache, aged 21: a critical self-appraisal, and plans for phase 2.
Timothy J Steiner, Raquel Gil-Gouveia, Andreas K Husøy, Rigmor Jensen, Zaza Katsarava, Lars Jacob Stovner

J Headache Pain· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of migraine medication use in Norway: A nationwide registry-based observational study.
Anker Stubberud, Solveig Borkenhagen, Francisco Oteiza, Aud Nome Dueland, Christoffer Bugge, Lars Jacob Stovner

Cephalalgia· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GBD2021: headache disorders and global lost health - a focus on children, and a view forward.
Timothy J Steiner, Andreas Husøy, Lars Jacob Stovner

J Headache Pain· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study.
Kent A Jamtøy, Wenche M Thorstensen, Lars J Stovner, Annika Rosén, Stine Maarbjerg

Cephalalgia· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insufficient sleep may alter cortical excitability near the migraine attack: A blinded TMS crossover study.
Martin Syvertsen Mykland, Martin Uglem, Lars Jacob Stovner, Eiliv Brenner, Mari Storli Snoen

Cephalalgia· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HARDSHIP databases: a forthcoming free good from the Global Campaign against Headache.
Timothy J Steiner, Andreas Husøy, Hallie Thomas, Lars Jacob Stovner

J Headache Pain· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global epidemiology of migraine and its implications for public health and health policy.
Timothy J Steiner, Lars Jacob Stovner

Nat Rev Neurol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous positive airway pressure in cluster headache: A randomized, placebo-controlled, triple-blind, crossover study.
Gøril Bruvik Gravdahl, Lars Aakerøy, Lars Jacob Stovner, Morten Engstrøm, Kai Ivar Müller

Cephalalgia· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine.
Lars Jacob Stovner, Knut Hagen, Erling Tronvik, Gøril Bruvik Gravdahl, Rami Burstein

Cephalalgia· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain thresholds and suprathreshold pain after sleep restriction in migraine - A blinded crossover study.
Jan Petter Neverdahl, Martin Uglem, Dagfinn Matre, Johannes Orvin Hansen, Morten Engstrøm, Lars Jacob Stovner

Cephalalgia· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Global Campaign turns 18: a brief review of its activities and achievements.
Timothy J Steiner, Gretchen L Birbeck, Rigmor H Jensen, Paolo Martelletti, Lars Jacob Stovner

J Headache Pain· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OnabotulinumtoxinA injection towards the SPG for treating symptoms of refractory chronic rhinosinusitis with nasal polyposis: a pilot study.
Kent Are Jamtøy, Erling Tronvik, Daniel Fossum Bratbak, Joan Crespi, Lars Jacob Stovner

Acta Otolaryngol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description.
Timothy J Steiner, Rigmor Jensen, Zaza Katsarava, Lars Jacob Stovner, Derya Uluduz

J Headache Pain· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study.

JAMA Neurol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High sensitivity C-reactive protein and risk of migraine in a 11-year follow-up with data from the Nord-Trøndelag health surveys 2006-2008 and 2017-2019.
Knut Hagen, Lars Jacob Stovner, John-Anker Zwart

J Headache Pain· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe COVID-19?
Anne Hege Aamodt, Marte H Bjørk, Erling A Tronvik, Eirik Alnes Buanes, Lars Jacob Stovner

Tidsskr Nor Laegeforen· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time trends of major headache diagnoses and predictive factors. Data from three Nord-Trøndelag health surveys.
Knut Hagen, Lars Jacob Stovner, John-Anker Zwart

J Headache Pain· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The crossover design for migraine preventives: an analyses of four randomized placebo-controlled trials.
Astrid Bjørke Jenssen, Lars Jacob Stovner, Erling Tronvik, Trond Sand, Grethe Helde

J Headache Pain· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of C-reactive protein levels on headache frequency in the HUNT study 2006-2008.
Knut Hagen, Lars Jacob Stovner, Kristian Bernhard Nilsen, Espen Saxhaug Kristoffersen, Bendik Slagsvold Winsvold

BMC Neurol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffusion tensor imaging in middle-aged headache sufferers in the general population: a cross-sectional population-based imaging study in the Nord-Trøndelag health study (HUNT-MRI).
Andreas Kattem Husøy, Live Eikenes, Asta K Håberg, Knut Hagen, Lars Jacob Stovner

J Headache Pain· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of headache disorders in the Eastern Mediterranean Region, 1990-2016: findings from the Global Burden of Disease study 2016.
Kia Vosoughi, Lars Jacob Stovner, Timothy J Steiner, Maziar Moradi-Lakeh, Seyed-Mohammad Fereshtehnejad

J Headache Pain· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis